Education
About Us
Working with TipRanks
Follow Us
Nanexa AB (DE:40M)
:40M
40M Stock Chart & Stats
Day’s Range― - ―
52-Week Range€0.05 - €0.24
Previous CloseN/A
Volume0.00
Average Volume (3M)59.00
Market Cap
€23.96M
Enterprise ValueN/A
Total Cash (Recent Filing)€10.29M
Total Debt (Recent Filing)kr2.20M
Price to Earnings (P/E)―
Beta1.07
Next Earnings
Oct 21, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding135,695,630
10 Day Avg. Volume179
30 Day Avg. Volume59
Financial Highlights & Ratios
PEG Ratio-0.10
Price to Book (P/B)2.53
Price to Sales (P/S)0.00
P/FCF Ratio-3.28
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
40M FAQ
What was Nanexa AB’s price range in the past 12 months?
Nanexa AB lowest stock price was €0.05 and its highest was €0.24 in the past 12 months.
What is Nanexa AB’s market cap?
Nanexa AB’s market cap is €23.96M.
When is Nanexa AB’s upcoming earnings report date?
Nanexa AB’s upcoming earnings report date is Oct 21, 2025 which is in 156 days.
How were Nanexa AB’s earnings last quarter?
Nanexa AB released its earnings results on May 06, 2025. The company reported -€0.005 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.005.
Is Nanexa AB overvalued?
According to Wall Street analysts Nanexa AB’s price is currently Overvalued.
Does Nanexa AB pay dividends?
Nanexa AB does not currently pay dividends.
What is Nanexa AB’s EPS estimate?
Nanexa AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Nanexa AB have?
Nanexa AB has 135,695,630 shares outstanding.
What happened to Nanexa AB’s price movement after its last earnings report?
Nanexa AB reported an EPS of -€0.005 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -7.692%.
Which hedge fund is a major shareholder of Nanexa AB?
Currently, no hedge funds are holding shares in DE:40M
---
Company Description
Nanexa AB
Nanexa AB (publ) operates as a nanotechnology drug delivery company. It operates PharmaShell, a nanobased drug delivery platform that is an atomic layer deposition. The company also develops NEX-18, which drives the development of a PharmaShell that targets myelodysplastic Syndrome and Acute Myeloid Leukemia. Nanexa AB (publ) was founded in 2007 and is based in Uppsala, Sweden.
---
Technical Analysis
Nanologica AB
―
Vivesto AB
―
Ascelia Pharma AB
―
Active Biotech AB
―
Klaria Pharma Holding AB
―
---